Awareness of Human Papillomavirus (HPV) and cervical cancer is imperative to reduce the risk of fatality of cancer in Pakistan. The screening of papillomavirus is the secondary prophylaxis against cervical cancer.
Director of University Clinic, Tuebingen (UKT), Germany, Dr Thomas Iftner expressed these views on Friday while delivering a lecture in the scientific sessions of the three-day IPVS Satellite Symposium on "Human Papillomavirus and Cervical Cancer," held at the International Centre for Chemical and Biological Sciences (ICCBS), University of Karachi.
He said that scientists from as many as 14 countries are participating in the international symposium, organised by Dr Panjwani Centre for Molecular Medicine and Drug Research (PCMD). Names of the participating countries included Germany, Belgium, USA, UK, Iran, Sweden, Indonesia, China, Cameron, Greece, Jordan, Nepal, Kazakhstan, and Sudan. The German expert underlined the importance of launching massive awareness programmes for the education of the Pakistani people.
Published in The Express Tribune, September 24th, 2022.
Comments are moderated and generally will be posted if they are on-topic and not abusive.
For more information, please see our Comments FAQ